This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Biogen Inc. rallied 7.0% to $216.03 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 7,354.02 and the Dow Jones Industrial Average falling 0.1% to 51,876.11.
This was the stock's third consecutive day of gains.
Biogen Inc. hit a new 52-week high, surpassing its previous peak of $206.67, which the company reached on June 25th.
The stock outperformed some of its peers, as Johnson & Johnson rose 4.0% to $254.66, Pfizer Inc. rose 2.6% to $24.29, and AbbVie Inc. rose 4.20% to $253.35.
Trading volume totaled 2.4 million, compared to the 50-day average of 1.1 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 26, 2026 16:34 ET (20:34 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments